LG H&H’s luxury skincare brand THE WHOO has surpassed 20 trillion won ($13.9 billion) in cumulative net sales, cementing its ...

Korean researchers have found no direct link between Covid-19 vaccination and menstrual changes such as abnormal uterine ...

In Korea, Eli Lilly and Novo Nordisk are pushing for national health insurance coverage for their diabetes drugs Mounjaro and ...

GC Biopharma reported a return to profitability in the first quarter of 2025, driven by improved blood product margins in ...

Korean biotech OliX Pharmaceuticals has locked in a $3 million milestone payment from China’s Jiangsu Hansoh Pharmaceutical ...

Pfizer Korea has secured reimbursement for Lorviqua (lorlatinib) as a first-line treatment for ALK-positive metastatic ...

The Korean Diabetes Association (KDA) has removed metformin as the preferred first-line treatment for type 2 diabetes in its newly revised 2025 Clinical Practice Guidelines for Diabetes, citing a lack ...

Dong-A Socio Holdings posted a 31 percent jump in first-quarter operating profit, powered by an 854 percent surge at ...

Korean patients with atopic dermatitis (AD) -- the most common form of eczema -- aren’t short on complaints, but for many, it ...

Korea’s ambitious plan to raise a K-Bio Vaccine Fund worth 1 trillion won ($703 million) for biotech innovation by 2025 is ...

Despite growing concerns from the medical community about inadequate training, lawmakers are continuing to propose bills ...

Ubix Therapeutics is one of the leading companies in Korea that has secured technology transfer and in-house clinical ...